SARS-CoV-2 Infection-Dependent Modulation in Vital Components of the Serum Profile of Severely SARS-CoV-2 Infected Patients
Mohammad Izhari
DOI: https://doi.org/10.2147/idr.s463238
2024-04-30
Infection and Drug Resistance
Abstract:Mohammad Asrar Izhari Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha, Saudi Arabia Correspondence: Mohammad Asrar Izhari, Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha, KSA, 65522, Saudi Arabia, Tel +966 547090882, Email Background: COVID-19 modulates many serological biomarkers during the progress of disease severity. The study aimed to determine COVID-19 severity-associated perturbance in the serum profile. Methods: A retrospective study including COVID-19-positive individuals (n = 405) was accomplished. The serum profile of COVID-19 participants was mined from laboratory records. Severity-associated alteration in the serum profile was evaluated using Pearson correlation, regression, VCramer, Bayesian posterior VCramer, and bias factor using R-base-RStudio-version-3.3.0 with a significant cut-off of p < 0.05. Results: Significantly different mean ± standard deviation (SD) (highly versus moderately severe) of C-reactive protein (CRP), ferritin, neutrophil-lymphocyte ratio (NLR), D-dimer, platelets, prothrombin time (PT), partial prothrombin time (PTT), troponin 1, lactate dehydrogenase (LDH), aspartate-aminotransferase (AST), alanine aminotransferase (ALT), and AST/ALT ratio was observed (p < 0.001). Highly severe COVID-19 associated with CRP, ferritin, NLR, in D-dimer, PT, PTT, troponin 1, AST/ALT ratio, AST and ALT (adjusted odds ratio (AOR): 1.346, 1.05, 1.46, 1.33, 1.42, 1.23, 4.07, 3.9, 1.24, 1.45, p < 0.001). CRP with ferritin (r = 0.743), NLR (r = 0.77), white blood cells (WBC) (r = 0.8), troponin1 with LDH (r = 0.757), and D-dimer with platelets (r = − 0.81) were highly correlated. X 2 pearson ( p < 0.001), V Cramer (0.71), Bayesian-V Cramer (0.7), and bias-factor (− 125) for troponin 1 indicate the strong association of troponin 1 level and with COVID-19 severity. X 2 pearson ( p < 0.001), V Cramer (1), Bayesian-V Cramer (0.98), and bias-factor (− 266.3) for NLR exhibited a very strong association of pathologic conditions with the high severity of the disease. Conclusion: These biomarkers of inflammation (CRP, Ferritin, NLR), coagulation disorders (D-dimer, PT, and PTT) cardiac abnormality (troponin 1), and liver injury (AST/ALT) could be crucial in low-medical resource settings as potential prognosticator/predictors of the COVID-19 severity and clinical outcomes. Moreover, the outcome of this study could be leveraged for the early prediction of disease severity during SARS-CoV or Middle East Respiratory Coronavirus (MERS-CoV) infection. Keywords: AST/ALT, NLR, PLR, regression, association, severity, COVID-19, biomarkers, D-dimer, CRP, ferritin, troponin 1, LDH, PT, PTT Graphical The resurgence of COVID-19 caused by variants and/or sub-variants of SARS-CoV-2, a pathogenic virus, 1 remains a noteworthy health concern across the globe despite the comprehensive vaccine drive. 2,3 COVID-19 dynamics and continuing burden are largely dependent on waning immune status and emerging SARS-CoV-2 variants/sub-variants. 3–5 Reports indicate that COVID-19 could eventuate in the endemic state instead of eliminated. 3,6 Furthermore, the trend of decrease in daily reported cases and the origin of a high number of the viral variants/sub-variants 7,8 even after four years of the pandemic suggest that COVID-19 could take longer to be endemic and SARS-CoV-2 regional circulation will continue. 3,6 Variation in COVID-19 outbreak in different regions has been reported 9 probably due to the dependence of the incidence of the disease on climatic conditions. 10 Additionally, COVID-19 causes substantial pulmonary pathology but also extrapulmonary clinical manifestations: arrhythmia, hepatocellular damage, coagulopathy, and coronary syndrome. 11 Moreover, in the last decades, apart from the SARS-CoV-2 outbreak in China in 2019, two other major outbreaks of the respiratory syndrome caused by SARS-CoV from China in 2002 12 and MERS-CoV from Saudi Arabia in 2012 13 were reported, however, reports suggest that the SARS-CoV-2 is less pathogenic and highly transmissible compared to SARS-CoV and MERS. 14 Because of the high transmissibility, it posed an unprecedented life threat to the global population. 15 Since coronaviruses exhibit similar clinical manifestations such as severe acute respiratory distress, 16 therefore, it could be anticipated that the perturbation in serum proteome brought about by SARS-CoV-2 infection could also help understand the pathophysiology of SARS-CoV and MERS-CoV infec -Abstract Truncated-
pharmacology & pharmacy,infectious diseases